Detalhe da pesquisa
1.
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma.
Invest New Drugs
; 38(4): 1056-1066, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31444589
2.
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
Cancer
; 125(7): 1124-1132, 2019 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30624766
3.
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.
Invest New Drugs
; 37(2): 297-306, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30132271
4.
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.
Breast Cancer Res Treat
; 149(1): 171-9, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25547219
5.
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 149(1): 151-61, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25537644
6.
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.
Invest New Drugs
; 32(6): 1246-57, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25142258
7.
Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells.
J Surg Res
; 185(1): 231-9, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23899511
8.
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.
Breast Cancer Res Treat
; 131(3): 933-7, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22083229
9.
Population pharmacokinetics of zanidatamab, an anti-HER2 biparatopic antibody, in patients with advanced or metastatic cancer.
Cancer Chemother Pharmacol
; 90(5): 399-408, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36102999
10.
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma.
J Clin Oncol
; 38(10): 1041-1049, 2020 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32031899
11.
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.
Invest New Drugs
; 27(2): 159-65, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18712502
12.
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy.
J Clin Oncol
; 37(29): 2592-2600, 2019 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31356140
13.
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer.
Cancer Chemother Pharmacol
; 67(4): 783-90, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20556613
14.
Poly(adp-ribose) polymerase inhibitors: a novel drug class with a promising future.
Cancer J
; 16(2): 83-90, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20404603
15.
Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells.
Clin Cancer Res
; 16(13): 3485-94, 2010 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20479064